![Joshua Reed](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joshua Reed
Finanzdirektor/CFO bei
ALKERMES PLC
Vermögen: 720 167 $ am 31.08.2026
Profil
Mr. Joshua Reed is a Chief Financial Officer & Senior Vice President at Alkermes Plc and an Independent Director at Scholar Rock Holding Corp.
He is on the Board of Directors at Scholar Rock Holding Corp.
Mr. Reed was previously employed as a Chief Financial & Accounting Officer by Omega Therapeutics, Inc., a Chief Financial Officer & Treasurer by Aldeyra Therapeutics, Inc., a Vice President & Head-Finance Operations by Bristol Myers Squibb Co., and a Vice President-Strategic Business Development by JPMorgan Chase & Co. He received his undergraduate degree from Rutgers State University of New Jersey and an MBA from Stephen M.
Ross School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.07.2026 | 12.679 ( 0,01 % ) | 720 167 $ | 31.08.2026 |
Aktive Positionen von Joshua Reed
| Unternehmen | Position | Beginn |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Direktor/Vorstandsmitglied | 18.03.2021 |
| ALKERMES PLC | Finanzdirektor/CFO | 15.09.2025 |
Ehemalige bekannte Positionen von Joshua Reed
| Unternehmen | Position | Ende |
|---|---|---|
| OMEA THER | Finanzdirektor/CFO | 31.05.2024 |
| ALDEYRA THERAPEUTICS, INC. | Finanzdirektor/CFO | 10.05.2022 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.07.2018 |
| JPMORGAN CHASE & CO. | Corporate Officer/Principal | 01.01.2005 |
Ausbildung von Joshua Reed
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
63
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
JPMorgan Chase & Co.
 JPMorgan Chase & Co. Major BanksFinance Provides banking, asset management, investment banking, credit card and mortgage services | Finance |
Aldeyra Therapeutics, Inc.
 Aldeyra Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for eye diseases | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stephen M. Ross School of Business
 Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alkermes Plc
 Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer | Health Technology |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Omega Therapeutics, Inc.
 Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
